| Detailed information |
|---|
| CancerLivER ID | 2056 |
| Biomarker | Putrescine, spermidine, spermine, N-acetylspermine and N-acetylspermidine |
| Biomarker Name/Symbol (given in Publication) | Putrescine, spermidine, spermine, N-acetylspermine and N-acetylspermidine |
| Biomolecule | Metabolite |
| Subject | Human |
| Degree of Validity | biomarkers for the characterization of lung and liver cancer; but not validated on independent dataset |
| Experimental Condition | HCC v/s Normal |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in the plasma of liver cancer patients than lung cancer patients |
| Level of significance | p < 0.05 |
| Source | Urine and Plasma |
| PMID | 27517900 |
| Type of Biomarker | Diagnostic |
| Pathway | anabolic biosynthetic and catabolic pathways of polyamines |
| Cohort | 50 healthy volunteers, 50 Liver cancer patients and 50 lung cancer patients. |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human lung cancer, liver cancer |
| Year of Publication | 2016 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |